UC-CARE

The 2026 prostate biopsy CPT changes mark a clear shift away from ultrasound-only workflows and toward MRI-guided and MRI-fusion prostate biopsy techniques. With the deletion of the catch-all CPT® 55700 and the introduction of new prostate biopsy CPT codes, biopsy approaches are no longer grouped together under a single procedural definition. Imaging guidance and targeting now play a central role in how prostate biopsies are classified. Many urology practices already recogniz

As of January 1, 2026, the long-standing prostate biopsy billing code CPT® 55700 has been retired by the American Medical Association and replaced with a more detailed set of procedure-specific CPT® codes. These updates distinguish prostate biopsy procedures by approach, imaging guidance, and whether MRI-identified lesions are targeted. The update reflects current prostate cancer biopsy practice, where MRI–ultrasound fusion biopsy plays an increasingly important role in detec

Current Procedural Terminology (CPT®) codes, developed and maintained by the American Medical Association (AMA), are updated annually to reflect changes in medical science, technology, and practice – ensuring billing and reimbursement accuracy, relevance, and alignment with modern care. CPT code 55700, the current standard for all types of prostate biopsy procedures, will be terminated starting January 1, 2026, to reflect significant advancements in the diagnosis of prostate

Focal therapy is a relatively recent addition to physician's toolkits to safely and effectively treat prostate cancer. It offers patients...

For hospitals, the Navigo 4D Fusion Navigation System is not just important for providing access to a gold standard of care — it's a...

The MRI fusion-guided biopsy of the future takes biopsies from collection, to analysis, to treatment planning, and provides numerous...

For many practices, the Navigo 4D Fusion Navigation System is not just a clinical innovation—it's a financial growth strategy. With low...

MRI-guided fusion biopsies have transformed prostate cancer detection, offering superior accuracy compared to traditional non-targeted...

A New Era in Prostate Cancer Diagnosis The ultrasound (US)-guided prostate biopsy – also called a “systematic” biopsy – was the...

Approximately 1 million prostate cancer biopsies are performed each year in the U.S., but a recent study found that standard US-guided...

Historically, ultrasound (US)-guided biopsies were the standard of care for diagnosing prostate cancer. However, these “blind” biopsies...

Prostate cancer is the leading cancer affecting men, comprising nearly 15% of all new cancer cases each year. 1 However, despite the...

Historically, ultrasound (US)-guided biopsies defined the standard of care for prostate cancer diagnostics. Recent and emerging evidence,...